A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 284 participants.
Also called NCT06672172
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 284 participants
- Registry
-
NCT06672172
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- China
- Registry status
- Completed
Technical summary
Registry record NCT06672172. Randomized; double masking; primary purpose treatment. Start 2024-09-25 (actual); primary completion 2025-11-13 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study of HRS-7535 Compared With Placebo in Adult Participants With Type 2 Diabetes and Inadequately Controlled With Diet and Exercise
- Acronym
- OUTSTAND-1
- Condition
- Type 2 Diabetes
- Intervention (Drug)
- HRS-7535 tablet
- Intervention (Drug)
- HRS-7535 tablet
- Intervention (Drug)
- HRS-7535 tablet
- Intervention (Drug)
- HRS-7535 placebo tablet
- Lead sponsor
- Shandong Suncadia Medicine Co., Ltd.
Record details
- Record id
cardio:ct-nct06672172- Content hash
f2cd791c5a81be88bb74c94b042c7f484953205c2b16e2f74640b83fe9bbda9c